Top

Published in:

01-02-2001

Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma

Authors: Won Seog Kim, Myung Min Kim, Hae Jin Choi, Sung-Soo Yoon, Mark Hong Lee, Keunchil Park, Chan H. Park, Won Ki Kang

Published in: Investigational New Drugs | Issue 1/2001

Title: Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma
Authors: Won Seog Kim
Myung Min Kim
Hae Jin Choi
Sung-Soo Yoon
Mark Hong Lee
Keunchil Park
Chan H. Park
Won Ki Kang
Publication date: 01-02-2001
Publisher: Kluwer Academic Publishers
Published in: Investigational New Drugs / Issue 1/2001
Print ISSN: 0167-6997
Electronic ISSN: 1573-0646
DOI: https://doi.org/10.1023/A:1006481423298

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2001

Excellent Response to Gemcitabine in a Massively Pre-Treated Woman with Extensive Cutaneous Involvement after Recurrence of Breast Cancer

Phase I Study of Irofulven (MGI 114), an Acylfulvene Illudin Analog, in Patients with Acute Leukemia

The Oral Fluorinated Pyrimidines

A Phase II Trial of Pyrazoloacridine (PZA) in Squamous Carcinoma of the Cervix – A Gynecologic Oncology Group Study

Phase I Study of N1-N11-Diethylnorspermine (DENSPM) Administered TID for 6 Days in Patients with Advanced Malignancies

A Phase I Study of Vitamin E, 5-Fluorouracil and Leucovorin for Advanced Malignancies

Keynote webinar | Spotlight on antibody–drug conjugates in cancer